Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Hormonal imbalances can cause heart rhythm issues, so checking hormone levels is crucial.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

A new drug strategy improves hair loss treatment with better results and safety.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Early diagnosis and treatment of TPP can prevent complications.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

PT-20 did not significantly improve gray hair repigmentation.

TAK-279 effectively reduces psoriasis symptoms and is safe.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Some thymic peptides can increase human hair growth, while others may inhibit it.

Diet can prevent bone issues but not hair loss in mice lacking vitamin D receptors.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document's conclusion cannot be provided because the document is not available or cannot be read.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

A new topical treatment for hair loss is effective and safe with faster results.

A new topical treatment for hair loss is effective and safe with faster results.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

A new topical treatment for hair loss is effective and safe with faster results.

A new topical treatment for hair loss is effective and safe with faster results.